Immunogenicity of two diphtheria-tetanus-whole cell pertussis-hepatitis B vaccines in infants: A comparative trial

Efficacy of antigen dosage on the hepatitis B vaccine response in infants born to hepatitis B-uninfected and hepatitis B-infected mothers

“…Except for mild pain at the injection site, there were no clinically meaningful injection-site ARs or systemic ARs at either vaccine dosage. This finding was consistent with those of previous safety studies of HB vaccines [14][15][16][17]. The results of our study indicated that the recombinant HB vaccine could be administered safely to neonates and infants and was well tolerated at either dosage.…”

Immunization with hepatitis B vaccine accelerates SLE-like disease in a murine model

“…HBV vaccine was related to neurological damage in humans, such as development of demyelinating events [72], multiple sclerosis and irritability [8,73,74]. Furthermore, evidence of cross reaction between antibodies against hepatitis B virus surface antigen and the myelin oligodendrocyte glycoprotein suggest molecular mimicry as the cause of HBVv related neuronal damage [75e77].…”